Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04614545 · ClinicalTrials.gov registry record · Phase 4
Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT04614545 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 70 participants.
The verdict
NCT04614545, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This study will study the effects associated with the prescription of phentermine in a virtual setting, comparing with prescription of phentermine via a standard face-to-face visit for patients with obesity or overweight.
Interventions
- BEHAVIORAL Exercise program
- DRUG Phentermine 37.5 Mg
- BEHAVIORAL Dietary program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-09-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04614545
The ClinicalTrials.gov registry entry for NCT04614545 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exercise program is the first listed.
NCT04614545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04614545 about?
NCT04614545 is a clinical study titled "Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity". This study will study the effects associated with the prescription of phentermine in a virtual setting, comparing with prescription of phentermine via a standard face-to-face visit for patients with obesity or overweight.
What is the current status of trial NCT04614545?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2021-01-01. Estimated completion is 2022-09-29.
What interventions are being tested in trial NCT04614545?
The interventions under investigation include: Exercise program (BEHAVIORAL), Phentermine 37.5 Mg (DRUG), Dietary program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04614545?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.